Metropolitan Life Insurance Company (MetLife)’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,040	Closed	-$339K	–	2873
2021 Q2	$339K	Buy	10,040 +1,493	+17%	+$38K	﹤0.01%	1772
2021 Q1	$200K	Hold	8,547	–	–	﹤0.01%	2019
2020 Q4	$246K	Hold	8,547	–	–	﹤0.01%	1800
2020 Q3	$173K	Hold	8,547	–	–	﹤0.01%	1863
2020 Q2	$257K	Buy	8,547 +3,166	+59%	+$114K	﹤0.01%	1642
2020 Q1	$169K	Buy	5,381 +278	+5%	+$9.66K	﹤0.01%	1685
2019 Q4	$240K	Buy	+5,103	New	+$147K	﹤0.01%	1787

Metropolitan Life Insurance Company (MetLife)'s CNST Position: Q3 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 10,040 shares — an estimated $339K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CNST in Q4 2019 and held it in 7 quarters. The position peaked at $339K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Metropolitan Life Insurance Company (MetLife) reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 10,040 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $339K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
Metropolitan Life Insurance Company (MetLife)'s Constellation Pharmaceuticals, Inc. position peaked at $339K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.